AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 284: R1494-R1505, 2003. First published January 23, 2003; doi:10.1152/ajpregu.00544.2002
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/6/R1494    most recent
00544.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, S. A.
Right arrow Articles by Erickson, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, S. A.
Right arrow Articles by Erickson, R. P.
Vol. 284, Issue 6, R1494-R1505, June 2003

Neuropeptides modulate rat chorda tympani responses

S. A. Simon1,2, Lieju Liu1, and Robert P. Erickson1

Departments of 1 Neurobiology and 2 Anesthesiology, Duke University, Durham, North Carolina 27710


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The neuropeptide leptin has been shown to selectively modulate rat chorda tympani (CT) responses to sweet tastants. To explore whether other neuropeptides can modulate such responses, rat whole nerve CT responses to NaCl, HCl, quinine HCl, and sucrose were measured while administering cholecystokinin-8 (CCK-8), substance P4-11 (SP4-11), or calcitonin gene-related peptide (CGRP). To avoid possible confounding effects on CT responses that take long times to develop, such as those that arise from intraperitoneal injections, we investigated the effects of the above peptides injected into the ipsilateral lingual artery (LA) on CT nerve responses during the initial seconds after a tastant was placed on the tongue. We found that CT responses to NaCl and HCl were increased by CCK-8 and decreased by CGRP. SP4-11 had no noticeable effect. Peptide-induced CT responses to quinine HCl or sucrose were too small to accurately detect. These data suggest that at short latencies, after local infusion via the LA, neuropeptides can alter CT responses in a peptide-specific manner.

taste; cholecystokinin; calcitonin gene-related peptide; substance P; lingual artery


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

THERE HAVE BEEN SEVERAL STUDIES regarding the modulation of gustatory responses by neuropeptides (8, 11, 20, 21, 26, 33, 43, 44). Because neuropeptides and their receptors are widely distributed in the central nervous system (CNS), their physiological effects on gustatory processes, including feeding (15, 17), could arise centrally or at the level of taste receptor cells (TRCs) and their associated primary neurons. Neuropeptides may rapidly reach the extracellular space surrounding the TRCs by being released from the TRCs themselves [cholecystokinin (CCK), vasointestinal peptide (VIP)], and/or their accompanying neurons via the activation of intra- and perigemal peptidergic neurons, whose peripheral terminals may contain calcitonin gene-related peptide (CGRP) and/or substance P (SP) (13, 14, 27, 28, 34, 35, 41, 47, 48). Neuropeptides may also be secreted into the bloodstream from other locations (e.g., leptin from adipose tissue) that may also influence gustatory responses (17, 33). However, in these cases, any modulation of the gustatory responses should require a longer latency (33). To avoid effects on CT responses that take long times to develop, such as those arising from intraperitoneal injections or from protein synthesis, we investigated the effects of selected neuropeptides injected directly into the LA on rat chorda tympani (CT) nerve responses during the initial few minutes a tastant was placed on the tongue.

Although many experiments have pointed to a role for neuropeptides in influencing taste, in some cases important controls were not performed, and in others, raw data were not shown (21). In many of the early experiments, neuropeptides were used that could be degraded by endogenous peptidases leaving open the possibility that some biologically active metabolite could produce this effect. In addition, many vasoactive peptides (e.g., CGRP) can produce changes in the blood pressure (BP) or the tongue's temperature and consequently may also alter CT responses through these mechanisms (23, 42, 47). For these cases it is not clear whether the effects of the peptides on CT responses are a consequence of interacting with TRCs, CT, and/or lingual nerve neurons, or whether they are a consequence of local changes in oxygen tension, BP, or the tongue's temperature. Here we have performed experiments that control for many of these variables.

One extensively studied neuropeptide is CCK, which, like leptin, modulates (decreases) food intake (17, 18), including a decrease in the intake of sucrose (17, 21, 46). After an intraperitoneal injection of CCK, rat CT responses to NaCl, sucrose, and quinine all increased, albeit at various times (43, 44). Because CCK did not alter the response to acid, it showed that it is tastant specific. In a similar study, it was reported that after two injections of CCK-8 into the rat jugular vein (JV), the tonic CT responses to 0.1 M NaCl and 0.3 M sucrose increased 3 and 8%, respectively (21). Single-unit recordings obtained in the nucleus of the solitary tract (NST) in response to several gustatory stimuli obtained before and after CCK-8 was injected into the rat JV were not significantly changed between 3 and 30 min (20). More recently, CCK has been found in TRCs and CCK-A type receptors have been found on TRCs from rat circumvallate and foliate papillae (27, 38). Moreover, the application of CCK-8 to these TRCs has been shown to increase calcium release from intracellular stores and modulate potassium currents (27, 38). Because of the importance of CCK as a taste modulator, we have reexamined the effects of a nonhydrolyzable CCK analog (CCK-8) on CT neurons by injecting it directly into the tongue via the lingual artery (LA).

SP is a neuropeptide that exhibits many physiological functions throughout the CNS, including the gustatory system (6, 37, 39). In one study it was shown that intraperitoneal injections of SP increased whole nerve rat CT responses to NaCl (43). In addition, SP-NK1 receptors are present on rat TRCs, suggesting that NK1-TRC interactions may play a role in modulating taste responses, perhaps via the release of SP from perigemal neurons (4). For these reasons we investigated the effects of SP on CT responses by injecting it into the LA.

CGRP receptors are distributed throughout the CNS, including perigemal neurons (45). Moreover, intracerebroventricular administration of CGRP has been shown to decrease food intake (36). For these reasons, we examined the direct effect of CGRP on CT responses.

In this study we have delivered neuropeptides into the LA and JV and have shown that within seconds, they can modulate CT response in a peptide-specific manner.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagent-grade salts were made up in distilled water. Peptides {[Tyr (SO3)27]-CCK fragment 26-33 amide (CCK-8), CGRP, and SP4-11} were obtained from Sigma Chemical (St. Louis, MO). Just before use, the peptides were dissolved in Krebs-Henseleit (KH) buffer (see below).

Subjects were nondeprived adult male Sprague-Dawley rats (230-300 g) obtained from Harlan or Charles River laboratories. As shown in Tables 1 and 2 and in the text, the effects of the neuropeptides were tested in 101 rats: 68 using the LA (28 for CCK-8, 19 for CGRP, and 21 for SP) and 33 using the JV (10 using CCK-8, 9 using CGRP, and 14 using SP). The animals were anesthetized by intraperitoneal injections of pentobarbital sodium (50 mg/kg, supplemented as necessary), and after tracheal cannulation they were placed in a nontraumatic headholder (10). Body temperature was maintained at 36-37.5°C by placing the rat on a feedback-controlled heated pad. The left CT nerve was exposed and placed on a tungsten wire electrode (9). An indifferent electrode was positioned on nearby muscle. Neural responses were led into an amplifier (A-M systems model 1700) that was fed into an integrator with a time constant of 1 s (7).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effects of lingual artery injections of peptides on the basal and tastant-evoked chorda tympani activity


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effects of jugular vein injections of peptides on the basal and 0.1 M NaCl-evoked chorda tympani activity

All experimental procedures were approved by the Institutional Animal Care and Use Committee at Duke University and were conducted in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" of the American Physiological Society (1).

Measurement of BP

In each animal, the BP was measured by cannulating the ipsilateral carotid artery with a Caldwell system pressure transducer (BPM-8802; Rougemont, NC). The output of the transducer was amplified and led into a DigiPack 1200 (Axon Instruments) and then into a computer, where it was recorded simultaneously with the CT response.

Injection into the LA: Immediate Perfusion of the Tongue

For cannulating the LA, the tissue around the trachea was exposed and the hyoid bone was removed. The proximal part of the LA was tied, and a polyethylene tube (PE-10) filled with KH solution (118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, 11 mM glucose, pH 7.4) was tied into the peripheral part of the LA (see Fig. 3B). The KH buffer could be immediately replaced with other solutions via a three-way valve (see Fig. 3B).

Injection into the JV

The ipsilateral external JV was exposed and cannulated with PE-50 polyethylene tubing filled with KH buffer. A volume of 100 µl KH buffer containing peptide was injected. As above, the cannula was connected to a three-way valve so after KH, other solutions in KH could be immediately replaced with each other without a break in the flow.

Tastant Stimulation of the Tongue

The anterior half of the tongue was pulled away from the mouth so that tastants could be easily applied. Solutions were continuously delivered to the tongue by a pressurized system at a flow rate between 20 and 30 ml/min (12). The continuous solution flow over the tongue during the various procedures served to reduce mechanical stimulation and changes in the tongue's surface temperature (12, 47). The NH4Cl solutions, used only to test the stability of the recordings, were always applied for 15 s, and the subsequent wash period between tastants was always 45 s. A recording was considered to be stable when the tonic 0.1 M NH4Cl response magnitudes at the beginning and the end of each stimulation series deviated by no more than 20%. Only responses from these stable recordings were used.

A 5 mM HEPES solution adjusted to pH 7.4 with KOH was used for washing the tongue. We define the activity during this wash phase as the basal activity.

Tastants were applied from 15 to >45 s. The peptides were usually injected ~15 s after the taste stimulus was applied. Solutions used for chemical stimuli were 0.1 M NH4Cl (NH), 0.1 M NaCl (Na), 0.01 M HCl, 3 mM quinine HCl (QHCl), and 0.5 M sucrose (S). The pH of these solutions (except for HCl) was between 5 and 7.4. Unless otherwise stated, each experiment was repeated at least three times in different animals.

Data Analysis

As a control, peptides were injected between tastant applications, while the tongue was washed with 5 mM HEPES buffer (see Figs. 2B and 9). For tests, the peptides were injected during the tonic phase of a response to a tastant (see Figs. 1, 2C, and 6). The volume injected was 100 µl unless otherwise mentioned. In a given animal, only data in which the peptides were tested for only a single tastant were used. That is, in each animal only one tastant (besides NH4Cl) was tested for one peptide. Unless otherwise stated, peptides were only applied a single time.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Method used for analyzing peptide-induced changes in chorda tympani (CT) responses: representative superimposed CT responses obtained from successive applications of 0.1 M NaCl. In the control (dark gray trace), 100 µl of Krebs-Henseleit (KH) buffer was injected into the jugular vein (arrow). After the tongue was washed, 0.1 M NaCl was reapplied, and at the arrow 5 µg CCK-8 in 100 µl of KH buffer was injected into the jugular vein (light gray trace). The dotted line in this trace represents the expected continuance of the response if the peptide was not injected. The amplitude of the response was calculated as the proportion of the maximum change in amplitude to 0.1 M NaCl on CCK-8 injection to the maximum change in amplitude of the response to NaCl with KH injected (see Table 1). Because the maximum increase in the response to CCK-8 was 21% and the control response did not change (= 1), the relative change was 1.21. Bar indicates duration of the stimulus.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Whole nerve CT responses during lingual artery (LA) perfusion of KH buffer. A: control whole nerve responses to 0.1 M NH4Cl (NH) and 0.1 M NaCl (Na) taken a few minutes after the LA was cannulated and again after 2 h. B: responses to sequential applications of 0.1 M NaCl interspersed after the 3rd NaCl application by an LA injection of KH buffer. There was no apparent effect of the KH injection on the response to 0.1 M NaCl. C: whole nerve responses to 4 applications of 0.1 M NaCl. During each application, 100 µl KH buffer was injected into the LA (arrows). No effect is evident. Bars indicate duration of the stimuli.

To test the effects of the peptides, the responses to them were compared with the effects on the responses evoked by injecting KH buffer alone. An example of this analysis is seen in Fig. 1, where successive CT responses to 0.1 NaCl were superimposed. In the initial application, KH buffer was injected into the JV, and in the subsequent response, 5 µg CCK-8 in KH buffer was injected into the JV. We accepted as effects clear changes in the form of the response from the response obtained with only the KH buffer. That is, the peptide-induced response had to be visually larger than the responses obtained by the injection of buffer. To determine whether peptides had an effect on the basal activity, we looked for abrupt changes in the slope that could not be accounted for by the injection itself, which, when it occurred, was very transient (see Fig. 8B). The changes in CT responses are given by the symbols (+/-) for no obvious change, (+) for obviously increased responses, and (-) for obviously decreased responses (see Tables 1 and 2). However, to give the reader a sense of the variability in the data we also give a descriptive statistical analysis of the data in which buffer and peptides were injected during the application of a tastant. We refer the reader to Fig. 1 for the methodology. To determine if any breaks occurred in the response, we simply continued the line between the pre- and postinjection activities (see dotted line, Fig. 1). We then measured the changes in the amplitude of the CT activity from the respective baselines to the maximum response evoked by either an injection of KH or the peptide. As a measure of the change that occurred upon the injection of peptides, we took the ratio of the maximum CT change with the injected peptide relative to the change with the injected KH buffer. For the example seen in Fig. 1, the ratio is 1.21/1 (since no change was seen on the injection of KH buffer). Tables 1 and 2 give the means ± SD of the amplitudes of the responses.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

LA Perfusion

Controls. effect of buffer alone. Figure 2A shows a representative tracing of the CT responses when the ipsilateral LA was cannulated and its proximal portion was clamped. Here NH4Cl and four tastants were applied to the dorsal tongue for 15 s; between each of the tastants a wash solution of 5 mM HEPES (pH 7.4) was flowed over the tongue for 45 s. These data also show that the CT responses remained stable for an extended period. In this regard, the LA was cannulated before obtaining the CT recording. Figure 2B shows that repeated applications of 0.1 M NaCl give reproducible responses and that an injection of 100 µl of KH buffer between tastant applications does not alter the subsequent tonic responses. Finally, injections of KH buffer during the tonic CT activity to NaCl did not alter the response (Fig. 2C). These data demonstrate that simply injecting a volume of 100 µl of KH buffer, once or repeatedly, does not alter the tonic CT responses to 0.1 M NaCl.

LINGUAL CIRCULATION. During the CT recordings in which the ipsilateral LA was occluded by the cannula (Fig. 3A), it was clear that some area of the ipsilateral tongue must have been receiving a sufficient supply of (oxygenated) blood to sustain the CT responses over periods of hours. However, it was previously shown that clamping the external carotid artery, which feeds the LA, diminished CT responses within 15 min (24). To better understand why this preparation remained viable for so long, we injected 200 µl of methylene blue (in KH) into the ipsilateral LA (Fig. 3B) and found that the entire ipsilateral side and the tip on the contralateral side turned blue (Fig. 3D), but the rest of the contralateral side remained pink (Fig. 3, C and D). However, when the contralateral LA was clamped and methylene blue (400 µl) in KH buffer was injected in the ipsilateral LA within seconds, the contralateral surface of the tongue also turned blue (Fig. 3E). Upon unclamping the contralateral LA, the blue color of the contralateral tongue faded, implying that the concentration of methylene blue decreased there (not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Circulation during occlusion of the LA with a cannula. For the purpose of taking these pictures, the tongue tip is clamped so that the tongue could be extended from the mouth. Note that when experiments are performed to measure CT responses, the rat is prone. A: dorsal surface of a rat tongue under control conditions where the blood flow is normal. B: LA perfusion, where the ipsilateral LA was perfused with methylene blue, which turned much of the ipsilateral tongue blue. The tubing filled with methylene blue, a syringe filled with dye, and a valve are also shown. Note that when experiments are performed to measure CT responses, the rat is prone. C: lower magnification of the control tongue (seen in A) after some of the methylene blue that was injected into the LA began to fade. D: a tongue from a different rat where both sides of the tongue's tip are blue from a unilateral LA injection of methylene blue. In this experiment, the rat's tongue was extended from its mouth with a hook in its lingual frenulum so as not to damage the tip. E: same tongue seen in A and C. After clamping the contralateral LA, methylene blue in KH buffer was reinjected into the ipsilateral LA. The picture shows that the dye is now present on both sides of the tongue. A, C, and E are from the same animal. B and D are taken from 2 different animals.

Hyperosmotic and hyposmotic solutions. To further understand the causes of the effects seen in the LA preparation, we have performed experiments to ascertain whether changes in osmotic pressure in the ipsilateral LA will alter CT responses to 0.1 M NaCl. Osmotic effects were found previously in a rat CT preparation with an intact blood supply (2); such data would serve as a good control for our preparation. The injection of 100 µl of 0.5 M NaCl transiently increased both the basal activity and the tonic CT response to 0.1 M NaCl (Fig. 4A, n = 3). Note that the increase in the tonic response was proportionally larger than the increase in the basal activity. We then tested whether hypotonic buffers of various compositions will change the CT response to NaCl and found that 100 µl injections of 0.01 M solutions of Na glutamate (Fig. 4B, n = 2), CaCl2 (Fig. 4C, n = 2), or KCl (Fig. 4D, n = 3) may have slightly decreased the basal activity. However, in the presence of 0.1 M NaCl on the dorsal tongue, the inhibitory responses of hyposmotic buffers on the CT responses were much larger than the small changes seen in the basal activity. Thus changing the osmotic pressure of the blood supply can modulate gustatory (CT) responses.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of tonicity on the CT response to 0.1 M NaCl. A: an LA injection of hyperosmotic (0.5 M) NaCl (pH 7.4) increases both the basal activity (initial arrow) and the tonic response to 0.1 M NaCl. LA injections of hyposmotic (0.01 M) solutions of Na glutamate (B), CaCl2 (C), or KCl (D) do not change or slightly decrease basal activity but markedly reduce the tonic responses to NaCl.

Neuropeptides: effect of CCK-8, CGRP, or SP4-11 on the basal CT activity. We next tested whether selected neuropeptides, at short times, could alter the basal CT responses. We choose concentrations that would evoke only small changes in the CT response and yet give consistent changes in the BP. After testing several peptide concentrations, we settled on using 10 µg CCK-8, 5 µg CGRP, and 1 µg SP4-11 (Fig. 5, A-C and Table 1). None of these three peptides evoked a consistent change of basal CT responses (see Table 1). At these concentrations, however, the peptides always changed the BP. The BP was increased by CCK-8 and decreased by CGRP and SP4-11, thereby demonstrating that the peptides were physiologically active at these concentrations. These data show that simply changing the BP did not markedly alter the basal activity or the responses to 0.1 M NH4Cl. Injecting only KH buffer did not evoke a change in BP (not shown, but see Fig. 8A).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of injections of neuropeptides into the LA on the basal CT activity and on blood pressure. A: infusion of 10 µg CCK-8 induced a small increase in basal CT activity and a transient increase in the blood pressure. B: infusion of 5 µg CGRP did not alter CT activity but produced, after a delay, a decrease in the blood pressure. C: infusion of 1 µg SP4-11 induced a small increase in CT activity and a transient decrease in the blood pressure. Arrows indicate times when neuropeptides were injected into the LA.

We did not use higher neuropeptide concentrations to investigate the tonic CT responses because they produced larger responses in the basal CT activity and the BP and often had effects that were irreversible. For example, 10 µg injections of SP4-11 greatly lowered the BP and essentially eliminated the CT responses, and even 5 µg SP4-11 injections caused a rapid reduction in the response to NaCl and NH4Cl that did not recover, even after a 10-min wash (data not shown).

Neuropeptides: effects of neuropeptides on tonic responses (LA preparation). We next investigated the effects of these three neuropeptides on the tonic CT responses. This was accomplished by injecting peptides into the LA during the tonic phase of the CT response to a gustatory stimulus.

CCK-8. CCK-8 was tested to determine its effects on the CT responses to four standard taste stimuli (see Table 1). The injection of 10 µg CCK-8 buffer into the LA produced, after a short delay, increases in the tonic CT responses evoked by NaCl (Fig. 6A) and HCl (Fig. 6B). The responses to QHCl (Fig. 6C) or sucrose (Fig. 6D) were not obviously altered by CCK-8 (see Table 1). Note that despite the changes in the CT response, e.g., to 0.1 M NaCl seen in Fig. 6A, the CT response returned to baseline, and the tonic response to NH4Cl was unchanged. These data show that CT responses can be rapidly modulated by the injection of CCK-8.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of CCK-8 on CT responses to tastants. The effects of an LA perfusion of 10 µg CCK-8 in 100 µl KH buffer (arrows) on the responses to 4 tastants. The responses to 0.1 M NH4Cl bracket each trial to ensure the stability of the recordings. CCK-8 increased the tonic responses to 0.1 M NaCl (A) and to 10 mM HCl (B). The responses to a solution of 3 mM quinine HCl (QHCl; C) and to 0.5 M sucrose (D) were not noticeably affected. Bars indicate the duration of the stimuli.

CGRP. CGRP's ability to alter CT responses was tested by injecting 5 µg of CGRP (in 100 µl of KH buffer) into the ipsilateral LA (Fig. 7). After the injection, the tonic responses to NaCl (Fig. 7A) and HCl (Fig. 7B) always decreased (see Table 1). In contrast, the responses to QHCl (Fig. 7C) and sucrose (Fig. 7D) were not apparently changed (Table 1). These data show that CGRP modulated the responses to NaCl and HCl, albeit in a different direction than CCK-8.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of calcitonin gene-related peptide (CGRP) on CT responses to tastants. The effects of an LA perfusion of 5 µg CGRP in 100 µl KH buffer (arrows). The responses to 0.1 M NH4Cl bracket each trial. CGRP decreased the tonic responses to 0.1 M NaCl (A) and 10 mM HCl (B). The responses to 3 mM QHCl (C) and 0.5 M sucrose (D) were not noticeably affected. Bars indicate the duration of the stimuli.

SP4-11. To test SP's ability to modulate CT responses, 1 µg SP4-11 in the KH carrier was injected into the LA. At this concentration it did not produce significant changes to any of the four tastants (data not shown, but see Table 1).

Injections of neuropeptides into the JV. Because some researchers that have tested the effects of neuropeptides on gustatory responses have injected them into the JV, we performed JV injections of peptides with NaCl as the tastant.

We initially looked to see how these neuropeptides altered the BP. Again concentrations were identified that would have a small effect on the basal CT activity (Table 2) but yet would give small but consistent changes in BP. As a control, we found that a 100-µl injection of KH buffer in the JV did not produce any changes in CT activity or in BP (Fig. 8A), but injections of 5 µg CCK-8 (in 100 µl KH) produced small transient increases in the basal CT responses, as well as in the BP (Fig. 8B). Injections of 0.5 µg CGRP did not alter the basal CT response but always produced a transient decrease in BP (Fig. 8C). However, injections of 5 µg CGRP evoked a small increase in spontaneous activity (2 +, 1 +/-) and a large decrease in BP that did not recover, even after several minutes of wash (data not shown). Finally, a 100-µl injection of 5 µg of SP4-11 did not produce consistent changes in the basal CT activity but always decreased the BP (Fig. 8D). Injections of 10 µg SP4-11 produced large decreases in BP and irreversible decreases in the CT responses (data not shown).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of jugular vein injections of neuropeptides on the basal CT activity and blood pressure. A: infusion of KH buffer did not alter the basal CT activity, the response to NH4Cl, or the blood pressure. B: infusion of 5 µg CCK-8 induced a small increase in CT activity and a transient increase in blood pressure. C: infusion of 0.5 µg CGRP did not alter CT activity but produced a transient decrease in blood pressure. D: infusion of 5 µg SP4-11 induced a small transient increase in CT activity and a biphasic change in the blood pressure. Arrows indicate times when peptides were injected.

To test whether these peptides injected into the JV can modulate the CT responses, we repeated the same sequence as we did with the LA perfusion method but only examined the effects for 0.1 M NaCl. As with the LA preparation, we found that injections of CCK-8 increased the response to 0.1 M NaCl (Fig. 1). However, injections of 0.5 µg CGRP did not alter the response to 0.1 M NaCl, despite the fact that it decreased the BP (Fig. 9). The responses to JV injections of 5 µg SP4-11 were quite variable and did not evoke marked changes. In this regard, even injections of 10 µg SP4-11 produced variable responses to 0.1 M NaCl (3 -, 1 +, 1 +/-).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 9.   Transient decreases in blood pressure do not alter CT responses to 0.1 M NaCl. This figure shows the CT responses to 10 applications of 0.1 M NaCl that are bracketed by responses to 0.1 M NH4Cl. The corresponding blood pressure responses are seen below. At the arrow, 0.5 µg CGRP in KH buffer was injected in the jugular vein, which produced a transient decrease in the blood pressure but did not markedly alter the CT responses to 0.1 M NaCl. Bars indicate duration of the stimuli.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

It was shown that neuropeptides injected directly into the LA could induce rapid changes in CT responses in a peptide-specific manner; i.e., CCK increased activity, SP had no apparent effect, and CGRP decreased activity.

The discussion is divided into two parts: the first part consists of a discussion of the LA preparation, and the second part involves a discussion of the effects of the three tested neuropeptides on CT responses.

LA Preparation

We have perfused chemicals directly into the tongue via the LA. One advantage of this method (over the intraperitoneal or JV methods) is that the effects of neuropeptides on CT responses are localized to the tongue, rather than involving other systemic effects. Another advantage, at least over the intraperitoneal method, is that the effects can be seen in a few seconds. In some studies, the responses obtained when the LA is occluded by a cannula give results similar to what is obtained with intact LAs. For example, the CT responses to 0.1 M NaCl are modulated in the same manner by CCK-8 with the LA occluded by the cannula (Fig. 6) and in JV experiments where the LA is not occluded (Fig. 1). We also found, as did Bradley (2) who used a preparation with an intact blood supply to the rat tongue, that injections of isotonic saline did not markedly alter CT responses, injections of hypertonic NaCl buffers rapidly increased the CT response to NaCl, and that injections of hyposmotic buffers rapidly decreased CT responses to NaCl (Figs. 2 and 4). Moreover, relative to the responses obtained under basal conditions, in the presence of 0.1 M NaCl these osmotic responses are amplified (Fig. 3), as they are with the peptides (see below). We have not explored the cellular physiology underlying the change in CT responses with tonicity but note that these effects follow local changes in osmolality.

In summary, we have demonstrated that the LA preparation is viable and is immediately and distinctly responsive to chemicals introduced into the lingual circulation.

We found it puzzling that the LA preparation with the ipsilateral LA occluded with the cannula remained viable for extended periods (Fig. 2A and 9). This may have occurred because the ipsilateral LA not only supplies blood to the ipsilateral tongue but also to the contralateral tip (Ref. 24 and Fig. 3). That is, clamping the ipsilateral external carotid artery does not prevent the flow of oxygenated blood from the contralateral LA into the taste buds at the tip on the ipsilateral side (see Fig. 3D). Because the tongue's tip contains many taste buds (40), it follows that the CT neurons on the ipsilateral side could be maintained by oxygenated blood flow from the contralateral LA. Tongue regions posterior to the tip may also remain viable. In this regard, on unilaterally clamping the lingual and external carotid artery for 1 wk, no differences were observed (at the light microscope level) between the two sides of the rabbit tongue (22). It was suggested that (perhaps through anastomoses) at the tip and posterior tongue, the occluded side received enough blood from the contralateral side to maintain its morphological characteristics. Our experiments are consistent with this possibility.1

It is very interesting that when the contralateral LA is clamped and methylene blue is injected into the ipsilateral LA, the dye is transported readily to both sides of the tongue. Assuming the anastomoses hypothesis, the reason that methylene blue remains predominately on the cannulated ipsilateral side when the contralateral circulation is intact could be that the normal BP from the contralateral side will prevent the dye from penetrating across the midline; this might arise from the high resistance of the anastomoses. In contrast, when the contralateral LA is clamped, the BP on that side will be low enough so that when methylene blue is injected into the ipsilateral LA, it can then be transported (via the BP gradient) into the contralateral tongue (Fig. 3E).

Rapid Modulation of CT Responses by Neuropeptides

Routes of neuropeptides from the bloodstream to TRCs. We have investigated whether the injection of neuropeptides into the LA can rapidly modulate tastant-evoked CT responses. Before discussing these findings, however, the pathways the peptides may take in being transported from the bloodstream to potential sites that could influence CT responses (TRCs, CT, or lingual fibers) will be reviewed. From intravascular taste experiments it appears that small organic molecules, such as saccharine, can rapidly diffuse through the capillary fenestra (32) and/or tight junctions of the endothelium into the extracellular space, where they can bind to receptors on TRCs to produce both a CT response and a sweet (or hedonically positive) taste sensation (2, 3, 16). Generalizing from saccharine, once neuropeptides exit the LA, the time for molecules to interact with TRCs will be short. If the distance between the blood supply and the taste receptor cells is even 10 µm (25), and if the diffusion constant of small peptides in buffer is ~ 10-6 cm2/s, then it will take ~1 s for peptides to reach the TRCs. So, at least theoretically, if peptides can diffuse out of the circulation, they can reach the TRCs in short times.

How long does it take peptides such as CGRP (mol wt 3,789), CCK-8 (mol wt 1,144), or leptin (176 amino acids) to diffuse from the bloodstream into the extracellular space (or to be released from lingual nerve fibers) where they can possibly interact with TRCs (or CT neurons) to alter their responses?2 As noted, after an intraperitoneal injection of leptin, which has been shown to bind to receptors on TRCs, the CT responses to saccharine and sucrose began to decrease in 10 min and reached their maximal decrease in 30 min (33). Given leptin's comparatively large size and that it was injected intraperitoneally, it follows that neuropeptides having much lower molecular weights would be expected to modulate CT in shorter times, especially if they were injected into the LA. In addition, vasodilators, such as SP and CGRP, that increase arterial permeability (29), should reduce the time it would take peptides to reach TRCs. Therefore, even though we have shown that neuropeptides may modulate CT responses in short times, it is not clear whether they do so by binding to receptors on TRCs, or by several other local mechanisms (see below).

A comment on the peptide-induced variability in some of the CT responses. Variable CT responses were obtained in many of the experiments involving the injection of the three tested neuropeptides. That is, in some experiments some of the responses increased, some decreased, and some did not change (see Tables 1 and 2). Other experiments have shown variability in the responses to the injection of peptides. In a detailed study involving the modulation of NST responses to tastants after a JV injection of CCK-8, the researchers excluded 75% of the data because of its intrinsic variability relative to the magnitude of a response (20).

What is the origin of the variability in the CT responses, especially those involving QHCl and sucrose (Table 1)? It cannot be argued that the time in which we looked for changes during the tonic response was too short, because during this period we have shown that CCK-8 (Fig. 6) and CGRP (Fig. 7) gave reproducible responses to NaCl and HCl (Table 1). We believe that the variability indicates that we were at the limits of our ability to measure these changes for these two tastants. We emphasize that this does not mean that changes did not occur, but rather we were unable to consistently detect them (see Table 1). For this reason we called these responses "No Apparent Effect" to emphasize that we did not have the resolution to determine whether or not an effect occurred.

Effects of peptides on CT responses. Unlike for saccharine and leptin, where the responses were taste specific and leptin receptors were found on TRCs (33), the site(s) where the neuropeptides interact to alter CT responses cannot be readily discerned in the present data. That is, using only information obtained from CT measurements, one cannot distinguish whether changes in the CT responses arise from the interaction of the neuropeptides with taste receptor cells, CT, or trigeminal nerve neurons, a change in tongue's surface temperature, and/or changes in BP. The contributions to these various possibilities may not be mutually exclusive and may even oppose one another (which may account for some of the variability). In an attempt to reduce two of these possibilities, solutions were continuously flowed over the tongue to reduce mechanosensory and thermal contributions to CT responses.

We have shown that CT responses are peptide specific. For example, unequivocal results were obtained on the modulation of CT responses to 0.1 M NaCl and 0.1 M HCl by CGRP and CCK-8. The CT responses to these two tastants were increased by CCK-8 (Table 1, LA; Table 2 JV) and decreased by CGRP (Table 1, LA). With regard to CCK-8, the increase in the CT response to NaCl is in good agreement with previous studies of the effects of CCK on CT responses to NaCl (21, 44). At high SP concentrations, the responses to NaCl decreased, but so did the basal CT activity, and these decreases were not readily reversible.

The same studies cited above reported that after intraperitoneal injections of CCK or JV injections of CCK-8, the CT response to sucrose was increased (21, 44). In the study that most closely resembled ours, 0.3 M sucrose was applied to rat tongues (with a dropper) for 45 s, and 5 µg CCK-8 was injected into the JV (21). Although no data were shown, the CT responses to sucrose increased 8 and 12% for the first and second CCK-8 injections, respectively (21). In our experiments, we did not find that CCK-8 altered the tonic CT response to sucrose (Fig. 6D and Table 1). In whole nerve CT responses, statistically significant changes at the level of 10% are difficult to obtain, especially when they are weak as they are for sucrose and quinine (see above discussion and Table 1).

CCK. Recent studies have shown that TRCs in rat fungiform papillae, unlike those in circumvallate papillae, do not contain CCK LI (27). If the TRCs in fungiform papillae do not contain CCK or its receptors, the mechanisms of how CCK modulates CT responses have to be indirect. In addition, we do not understand how CCK produces transient increases in the BP, because intraperitoneal injections of CCK usually cause a decrease in BP (30). If CCK-8 gets past the blood-brain barrier, it causes an increase in BP (19). On the other hand, it may be that the small transient BP increases may be a response to the activation of nociceptors by CCK (31).

SP. We also investigated whether SP can alter CT responses. We expected to find some effects of SP4-11 given that NK-1 receptors are on taste cells in fungiform papillae (4). Indeed, in a previous study, intraperitoneal injections of SP (not the nonhydrolyzable analog) were found to increase whole nerve rat CT responses to NaCl (43). In our experiments, however, we found that LA injections of 1 µg SP4-11 did not alter CT responses to any of the tastants but consistently produced a transient and lowering of the BP. It is hard to argue that SP4-11 did not get to particular site(s) during this time because CGRP is a considerably larger peptide and it clearly modulated CT responses. Some of the effects that have been attributed to changes when peptides are injected intraperitoneally could arise from long-term vasoactive mechanisms that could lead to changes in the tongue's temperature that, in turn, could modulate gustatory responses to tastants in a different manner (5). In this regard, at higher SP4-11 concentrations, CT responses were diminished and the BP was greatly reduced. At higher brain centers, such as the NST, injection of SP has been demonstrated to modulate single-unit responses to tastants (8).

CGRP. We found that LA injections of CGRP decreased CT responses to NaCl and HCl (Fig. 7). That the effect in the response to CGRP (decrease) is opposite to the effect of CCK-8 (increase) suggests that different mechanisms are involved. One early possibility that we considered to rationalize the CGRP data is that the CT changes may be correlated with the changes in BP, because reducing the BP causes an approximately linear decrease of the CT responses to 0.3 M NaCl (24). Using these data, a decrease in BP of 20 mmHg (say from 100 to 80) decreased the CT response only ~8%. From these data, together with the above discussion, it is unlikely that BP changes can account for the changes that we have seen with CGRP (Figs. 7 and 9) or with CCK-8 (Figs. 1 and 6). However, at larger peptide concentrations the decreases in CT responses that we have seen could arise from changes in BP.

In summary, we have shown that neuropeptides can directly and rapidly modulate gustatory neural activity. These changes could underlie some of the behavioral changes produced by neuropeptides in modulating food intake.


    ACKNOWLEDGEMENTS

We thank C. Shao for doing many of the experiments. This work was supported in part by National Institutes of Health Grant DC-01065 and, in part, by Philip Morris USA, Inc.


    FOOTNOTES

Address for reprint requests and other correspondence: S. A. Simon, Dept. of Neurobiology, Duke Univ., Durham, NC 27710 (E-mail: sas{at}neuro.duke.edu).

1 The connection of the lingual circulation at the tongue's tip may explain how peptides injected into the ipsilateral LA are transported into the circulation to change the systemic BP (Fig. 5), although the peptides could also be transported via the intact ipsilateral venous system to cause these changes.

2 CGRP and SP and CCK are present on the terminals of intra- and perigemal fibers (14, 41). If these neurons are activated and release peptides (perhaps by becoming ischemic, which will result in a lower pH), the times may be even shorter than for leptin that is synthesized in adipose tissue and thus must reach fungiform papillae through the circulation.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published January 23, 2003;10.1152/ajpregu.00544.2002

Received 6 September 2002; accepted in final form 23 January 2003.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002[Free Full Text].

2.   Bradley, RM. Electrophysiological investigations of intravascular taste using perfused rat tongue. Am J Physiol 224: 300-304, 1973[Free Full Text].

3.   Bradley, RM, and Mistretta CM. Intravascular taste in rats as demonstrated by conditioned aversion to sodium saccharin. J Comp Physiol Psychol 75: 186-189, 1971[Web of Science][Medline].

4.   Chang, GQ, Vigna SR, and Simon SA. Localization of substance P NK-1 receptors in rat tongue. Regul Pept 63: 85-89, 1996[Web of Science][Medline].

5.   Cruz, A, and Green BG. Thermal stimulation of taste. Nature 403: 889-892, 2000[Medline].

6.   Cuello, AC, Galfre G, and Milstein C. Detection of substance P in the central nervous system by a monoclonal antibody. Proc Natl Acad Sci USA 76: 3532-3536, 1986.

7.   Dahl, M, Erickson RP, and Simon SA. Neural responses to bitter compounds in the rat. Brain Res 756: 22-34, 1997[Web of Science][Medline].

8.   Davis, BJ, and Smith DV. Substance P modulates taste responses in the nucleus of the solitary tract of the hamster. Neuroreport 8: 1723-1727, 1997[Web of Science][Medline].

9.   Elliott, EJ, and Simon SA. The anion in salt taste: a possible role of tight junctions. Brain Res 535: 9-17, 1990[Web of Science][Medline].

10.   Erickson, RP. Non-traumatic headholders for mammals. Physiol Behav 1: 97-99, 1966.

11.   Esakov, AE, and Serova ON. Influence of substance P on taste receptor organ and salt intake in rats. Neuroscience 14: 321-327, 1988.

12.   Faurion, A, and Vayssettes-Courchay C. Taste as a highly discriminative system: a hamster intrapapillar single unit study with 18 compounds. Brain Res 512: 317-322, 2002.

13.   Finger, TE, Nelson GM, Bryant B, and Moore PA. Intragemmal and perigemmal fibers in taste buds: immunocytochemistry and differential sensitivity to capsaicin. Soc Neurosci Abstr 20: 980, 1994.

14.   Finger, TE, and Simon SA. The cell biology of lingual epithelia. In: The Neurobiology of Taste and Smell, edited by Finger TE, Silver WL, and Restrepo D.. New York: Wiley-Liss, 2002, p. 287-314.

15.   Fink, H, Rex A, Voits M, and Voigt JP. Major biological actions of CCK---a critical evaluation of research findings. Exp Brain Res 123: 77-83, 1998[Web of Science][Medline].

16.   Fishberg, AM, Hitiz W, and King RH. Measurement of the circulation time with saccharin. Proc Soc Exp Biol Med 30: 651-652, 1933.

17.   Friedman, JM, and Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 783-770, 2002.

18.   Gibbs, J, Young RC, and Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973[Web of Science][Medline].

19.   Gillis, RA, Quest JA, Pagani FD, Da Silva AM, Jensen RT, Garvey Q, and Hamosh P. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat. J Pharmacol Exp Ther 224: 408-414, 1983[Abstract/Free Full Text].

20.   Giza, BK, Scott TR, and Antonucci RF. Effect of cholecystokinin on taste responses in rats. Am J Physiol Regul Integr Comp Physiol 258: R1371-R1379, 1990[Abstract/Free Full Text].

21.   Gosnell, BA, and Hsiao S. Effects of cholecystokinin on taste preference and sensitivity in rats. Behav Neurosci 98: 452-460, 1984[Web of Science][Medline].

22.   Gotze, W, and Lierse W. Die Blutgefasse der Kaninachenzunge, die kontralateran anasotmosen beider zungenhalfen in der wirkung nach eineseitger ligatur der A. lingualis oder A. carotis externa. Morph Jb 113: 119-132, 1969.

23.   Hellekant, G. On the relation between the chorda tympani nerve response, arterial oxygen tension and blood flow in the tongue of the rat. Acta Physiol Scand 82: 453-459, 1971[Web of Science][Medline].

24.   Hellekant, G. The effect of changes in the blood flow to the tongue on the chorda tympani response in rat. Acta Physiol Scand 82: 145-153, 1971[Web of Science][Medline].

25.   Hellekant, G. The blood circulation of the tongue. In: Frontiers of Oral Physiology, edited by Kawmura Y.. Basel: Karger, 1976, p. 130-145.

26.   Herness, MS, and Gilbertson TA. Cellular mechanisms of taste transduction. Annu Rev Physiol 61: 873-900, 1999[Web of Science][Medline].

27.   Herness, S, Zhao FL, Lu SG, Kaya N, and Tainsheng S. Expression and physiological actions of cholecystokinin in rat taste receptor cells. J Neurosci 22: 10028-10029, 2003.

28.   Herness, MS. Vasoactive intestinal peptide (VIP)-like immunoreactivity in rodent taste cells. Neuroscience 33: 411-419, 1989[Web of Science][Medline].

29.   Holzer, P, Peskar BM, Peskar BA, and Amann R. Release of calcitonin gene-related peptide induced by capsaicin in the vascularly perfused rat stomach. Neurosci Lett 108: 195-200, 1990[Web of Science][Medline].

30.   Hurle, M, Morin-Surun MP, Foutz AS, Boudinot E, and Denavit-Saubie M. Different targets involved in the effect of cholecystokinin on respiration. Eur J Pharmacol 118: 87-96, 1985[Web of Science][Medline].

31.   Kamei, J, and Zushida K. The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic mice. Brain Res 892: 370-375, 2001[Web of Science][Medline].

32.   Kanazawa, H. Fine structure of the canine taste bud with special reference to gustatory cell functions. Arch Histol Cytol 56: 533-548, 2002.

33.   Kawai, K, Sugimoto K, Nakashima K, Miura H, and Ninomiya Y. Leptin as a modulator of sweet taste in mice. Proc Natl Acad Sci USA 97: 11044-11049, 2002[Abstract/Free Full Text].

34.   Kinnman, E, and Aldskogius H. Collateral reinnervation of taste buds after chronic sensory denervation: a morphological study. J Comp Neurol 270: 569-574, 1988[Web of Science][Medline].

35.   Kinnman, E, and Aldskogius H. The role of substance P and calcitonin gene-related peptide containing nerve fibers in maintaining fungiform taste buds in the rat after a chronic chorda tympani nerve injury. Exp Neurol 113: 85-91, 1991[Web of Science][Medline].

36.   Krahn, DD, Gosnell BA, Levine S, and Morley JE. Effects of calcitonin gene-related peptide on food intake. Peptides 5: 861-864, 1984[Web of Science][Medline].

37.   Li, JL, Ding YQ, Shigemoto R, and Mizuno N. Distribution of trigeminothalamic and spinalthalamic tract neurons showing substance P receptor-like immunoreactivity in the rat. Brain Res 719: 207-212, 1996[Web of Science][Medline].

38.   Lu, SG, Kaya N, and Herness MS. Cholecystokinin increases intracellular calcium levels in rat posterior taste receptor cells. Chem Senses 25: 685, 2000.

39.   Lundberg, JM, Hokfelt T, Anggard A, Pernow B, and Emson P. Immunohistochemical evidence for substance P immunoreactive nerve fibers in taste buds of the cat. Acta Physiol Scand 107: 389-391, 1979[Web of Science][Medline].

40.   Miller, IJ, Jr. Anatomy of the peripheral taste system. In: Handbook of Taste and Olfaction, edited by Doty RL.. New York: Dekker, 1995, p. 521-547.

41.   Nagai, T, Kim DJ, Delay RJ, and Roper SD. Neuromodulation of transduction and signal processing in the end organs of taste. Chem Senses 21: 353-365, 1996[Abstract/Free Full Text].

42.   Nakamura, M, and Kurihara K. Temperature dependence of amiloride-sensitive and -insensitive component of rat taste nerve response to NaCl. Brain Res 444: 159-164, 1988[Web of Science][Medline].

43.   Serova, ON. [The peptidergic mechanisms controlling specialized appetites and taste afferentation]. Zh Vyssh Nerv Deiat Im I P Pavlova 43: 358-370, 1993[Medline].

44.   Serova, ON, and Esakov AI. [Activating effect of cholecystokinin-pancreozymin on the taste receptor system on the rat]. Fiziol Zh SSSr 71: 1271-1277, 1985.

45.   Van Rossum, D, Hanisch UK, and Quiron R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Behav Rev 21: 649-678, 1997[Web of Science][Medline].

46.   Waldbillig, RJ, and O'Callaghan M. Hormones and hedonics cholecystokinin and taste: a possible behavioral mechanism of action. Physiol Behav 25: 25-30, 1980[Medline].

47.   Wang, Y, Erickson RP, and Simon SA. Modulation of chorda tympani nerve activity by lingual nerve stimulation. J Neurophysiol 73: 1468-1483, 1995[Abstract/Free Full Text].

48.   Welton, J, Taylor R, Porter AJ, and Roper SD. Immunocytochemical survey of putative neurotransmitters in taste buds from Necturus maculous. J Comp Neurol 324: 509-521, 1992[Web of Science][Medline].


Am J Physiol Regul Integr Comp Physiol 284(6):R1494-R1505
0363-6119/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
P. Kovacs and A. Hajnal
Altered Pontine Taste Processing in a Rat Model of Obesity
J Neurophysiol, October 1, 2008; 100(4): 2145 - 2157.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
V. Lyall, G. L. Heck, T.-H. T. Phan, S. Mummalaneni, S. A. Malik, A. K. Vinnikova, and J. A. DeSimone
Ethanol Modulates the VR-1 Variant Amiloride-insensitive Salt Taste Receptor. I. Effect on TRC Volume and Na+ Flux
J. Gen. Physiol., May 31, 2005; 125(6): 569 - 585.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
V. Lyall, G. L. Heck, T.-H. T. Phan, S. Mummalaneni, S. A. Malik, A. K. Vinnikova, and J. A. DeSimone
Ethanol Modulates the VR-1 Variant Amiloride-insensitive Salt Taste Receptor. II. Effect on Chorda Tympani Salt Responses
J. Gen. Physiol., May 31, 2005; 125(6): 587 - 600.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/6/R1494    most recent
00544.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, S. A.
Right arrow Articles by Erickson, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, S. A.
Right arrow Articles by Erickson, R. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.